Abstract
Patient"related factors, especially markers of inflammatory response, are prognostic in many common solid cancers. Here we review how such markers, in particular the acute"phase proteins C"reactive protein and albumin and a differential white cell count, can predict treatment outcomes in cancer patients. The review examines the literature pertaining to surgery, chemotherapy, and radiotherapy and discusses how inflammatory markers might be incorporated into the planning and monitoring of cancer treatments.
| Original language | English |
|---|---|
| Pages (from-to) | 475-478 |
| Number of pages | 4 |
| Journal | Clinical Pharmacology and Therapeutics |
| Volume | 90 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2011 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- biomarkers
- cancer
- treatment
Fingerprint
Dive into the research topics of 'Use of inflammatory markers to guide cancer treatment'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver